Axis 1, “Clinical Research and Treatment” is jointly directed by Anne-Louise Lafontaine and Sylvain Chouinard. This axis is associated with a first infrastructure, the participants’ registry.
This axis focuses mainly on the clinical aspects of the participants’ care. This includes research on cardinal motor symptoms and dyskinesias.
While the continuation and optimization of current pharmacological treatments remain essential, developing new therapeutic approaches is urgent. For example, deep brain stimulation is an increasingly used approach in Parkinson’s patients and is now being considered even before the disease reaches an advanced stage.
Other treatment modalities, such as transcranial magnetic stimulation, exercise training programs, and dance and music therapy, are also being developed. Their beneficial action on the symptoms of the disease is increasingly documented and exploited.
All these original and innovative approaches demonstrate the inspiring and central role of many groups in Quebec in the treatment and management of Parkinson’s disease.